HIGHLIGHTS
- who: Jaeyong Jung from the Italy Affiliated Hospital of Hebei University have published the research work: TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes, in the Journal: (JOURNAL)
- future: The above proteomic and metabolic findings have therapeutic implications suggesting that manipulation of mitochondrial dynamics and inhibition of key metabolic enzymes or transporters offer new perspectives of treatment strategies for B cell malignancies especially those with TRAF3 deletions or relevant alterations.
SUMMARY
Tumor necrosis factor receptor-associated factor 3 (TRAF3), a cytoplasmic adaptor protein of the TRAF . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.